Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Steven Avruch | Chief Legal Officer | 2024-02-05 | 10,812 | $1.20 | $13.00kSell |
Azadeh Golipour | Chief Technology Officer | 2024-02-05 | 12,232 | $1.20 | $14.70kSell |
Erik Ostrowski | Interim CEO President and CFO | 2024-02-05 | 13,099 | $1.20 | $15.74kSell |
Essra Ridha | Chief Medical Officer | 2024-02-05 | 16,953 | $1.20 | $20.36kSell |
Azadeh Golipour | Chief Technology Officer | 2023-06-12 | 111 | $1.21 | $133.76Sell |
Azadeh Golipour | Chief Technology Officer | 2023-06-12 | 5,463 | $1.19 | $6.50kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Bruce Booth | 12.41% | 5,567,289 | $7.01M | Insider |
Atlas Venture Fund X LP | 10.60% | 4,756,478 | $5.99M | Insider |
Atlas Venture Life Science Advisors LLC | 10.12% | 4,541,381 | $5.72M | Institution |
Clarus Lifesciences Iii LP | 9.91% | 4,443,487 | $5.60M | Insider |
Bml Capital Management LLC | 8.92% | 4,001,627 | $5.04M | Institution |
Atlas Venture Associates X LP | 8.27% | 3,710,052 | $4.67M | Insider |
Blackstone Holdings Ii LP | 6.60% | 2,962,325 | $3.73M | Insider |
Scott Requadt | 6.60% | 2,962,325 | $3.73M | Insider |
Newtyn Management LLC | 6.09% | 2,734,175 | $3.45M | Institution |
Vanguard Group Inc | 3.57% | 1,601,834 | $2.02M | Institution |